John Colin Meyer Net Worth & Insider Trades

John Colin Meyer - Chief Research Officer, Reata Pharmaceuticals Inc

As of January 5, 2022

What is John Colin Meyer's Net Worth?

The current estimated net worth of Reata Pharmaceuticals Inc's Chief Research Officer, John Colin Meyer, is estimated to be about $19.66M . John Colin Meyer owns about 17,000 units of Reata Pharmaceuticals Inc common stock. In the last 6 years at Reata Pharmaceuticals Inc, John Colin Meyer has sold an estimated value of $17.17M worth.

What is John Colin Meyer's Past Insider Trading?

John Colin Meyer's largest purchase order was 7,000 units , worth over $113.82K on August 17, 2016. John Colin Meyer's largest sale order was 60,000 units , worth over $8.55M on June 16, 2021. In total, John Colin Meyer has made about 16 transactions over 6 years of their time at Reata Pharmaceuticals Inc. John Colin Meyer usually trades in January, with the busiest year in 2019 and 2016.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is John Colin Meyer's' Mailing Address?

  • Mailing address is C/o Reata Pharmaceuticals, Inc. 2801 Gateway Dr. Suite 150 Irving TX 75063 TX

Reata Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Total
J. Warren Huff 2020 $636,400 $413,660 - $5,000 $5,000 $6,396,130
J. Warren Huff 2019 $578,500 $600,540 - $16,715 $16,715 $5,542,605
J. Warren Huff 2018 $534,000 $400,500 - - - $934,500
Manmeet S. Soni 2020 $545,900 $445,700 - $136,125 $136,125 $4,465,894
Manmeet S. Soni 2019 $179,385 $408,873 - $70,243 $70,243 $12,261,587
Dawn C. Bir 2020 $422,000 $239,900 - $5,000 $5,000 $3,871,542
Dawn C. Bir 2019 $375,100 $287,550 - $3,500 $3,500 $1,975,899
Colin J. Meyer, M.D. 2020 $513,951 $381,400 - - - $4,233,520
Colin J. Meyer, M.D. 2019 $445,600 $389,467 - - - $2,182,780
Colin J. Meyer, M.D. 2018 $417,000 $208,500 - - - $625,500
Michael D. Wortley 2020 $421,100 $339,500 - - - $3,965,242
Michael D. Wortley 2019 $382,800 $341,400 - - - $2,033,949
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1358762/000156459021022192/reta-def14a_20210610.htm

What are Reata Pharmaceuticals Inc's Past Insider Trades?

Reata Pharmaceuticals Inc's most recent insider trade came on January 4, 2022 by Singh Manmeet Soni who bought 16,000 units worth $419.56K . In the last 5 years, insiders at Reata Pharmaceuticals Inc have sold an estimated value of $113.89M and bought an estimated value of $138.22M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Douglas Jason Wilson, Executive VP Operations,  Elaine Castellanos, VP,  and R. Kent McGaughy Jr., Director .

REATA PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1